# Controlled Human Malaria Infection (CHMI) After Immunization With Cryopreserved Plasmodium Falciparum Sporozoites Under Chloroquine Prophylaxis

> **NCT01728701** · PHASE1 · COMPLETED · sponsor: **Sanaria Inc.** · enrollment: 30 (actual)

## Conditions studied

- Malaria
- Plasmodium Falciparum

## Interventions

- **BIOLOGICAL:** PfSPZ Challenge
- **BIOLOGICAL:** Normal Saline (NS)

## Key facts

- **NCT ID:** NCT01728701
- **Lead sponsor:** Sanaria Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-09
- **Primary completion:** 2013-12
- **Final completion:** 2014-02
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2017-05-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01728701

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01728701, "Controlled Human Malaria Infection (CHMI) After Immunization With Cryopreserved Plasmodium Falciparum Sporozoites Under Chloroquine Prophylaxis". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01728701. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*